EXOCRINE PANCREAS CARCINOMA
Clinical trials for EXOCRINE PANCREAS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXOCRINE PANCREAS CARCINOMA trials appear
Sign up with your email to follow new studies for EXOCRINE PANCREAS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets hard-to-treat RAS cancers
Disease control OngoingThis study tests a combination of two drugs, palbociclib and binimetinib, in people with cancers that have a RAS mutation, including certain ovarian and pancreatic cancers. The goal is to see if the combination can slow cancer growth better than one drug alone. About 199 adults w…
Matched conditions: EXOCRINE PANCREAS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes in a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers (solid tumors, lymphoma, or myeloma) had their tumors genetically screened. Those with specific genetic c…
Matched conditions: EXOCRINE PANCREAS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC